Drug Shortage Report for SANDOZ AMPHETAMINE XR
Report ID | 9451 |
Drug Identification Number | 02457318 |
Brand name | SANDOZ AMPHETAMINE XR |
Common or Proper name | SANDOZ AMPHETAMINE XR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROAMPHETAMINE SACCHARATE DEXTROAMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE AMPHETAMINE SULFATE |
Strength(s) | 3.75MG 3.75MG 3.75MG 3.75MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-05-05 |
Estimated end date | 2017-07-17 |
Actual end date | 2017-07-31 |
Shortage status | Resolved |
Updated date | 2017-09-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-05-08 | English | Compare |
v2 | 2017-05-08 | French | Compare |
v3 | 2017-06-26 | English | Compare |
v4 | 2017-06-26 | French | Compare |
v5 | 2017-09-07 | English | Compare |
v6 | 2017-09-07 | French | Compare |
Showing 1 to 6 of 6